Socioeconomic inequalities in completion of hepatitis B vaccine series among Korean women: Results from a nationwide interview survey

Vaccine

Volumn 30, Issue 40, 2012, Pages 5844-5848

  Park, Boyoung ^a   Choi, Kui Son ^a   Lee, Hoo Yeon ^b   Jun, Jae Kwan ^a   Park, Eun Cheol ^c  

^a National Cancer Center   (South Korea)

^b Dankook University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Female; Hepatitis B vaccines; Inequalities; Socioeconomic status

Indexed keywords

HEPATITIS B VACCINE;

ACADEMIC ACHIEVEMENT; ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; INCOME; INTERVIEW; KNOWLEDGE; OCCUPATION; PRIORITY JOURNAL; SOCIAL STATUS; URBAN AREA; VACCINATION;

ADULT; AGED; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; INCOME; LOGISTIC MODELS; MIDDLE AGED; REPUBLIC OF KOREA; SOCIAL CLASS; SOCIOECONOMIC FACTORS;

EID: 84864809074     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.07.022     Document Type: Article

References (35)

1. Kao J.H., Chen D.S. Global control of hepatitis B virus infection. Lancet Infect Dis 2002, 2:395-403.
2. World Health Organization. Hepatitis B. Fact sheets. http://www.who.int/mediacentre/factsheets/fs204/en/.
3. Chae H.B., Kim J.H., Kim J.K., Yim H.J. Current status of liver diseases in Korea: hepatitis B. Korean J Hepatol 2009, 15(Suppl. 6):S13-S24.
4. Korean Statistical Information Service (KOSIS). The trend of hepatitis B surface antigen prevalence. http://www.kosis.kr/.
5. Jung K.W., Park S., Kong H.J., Won Y.J., Lee J.Y., Park E.C., et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat 2011, 43:1-11.
6. Batayneh N., Bdour S. Risk of perinatal transmission of hepatitis B virus in Jordan. Infect Dis Obstet Gynecol 2002, 10:127-132.
7. Kong H., Kim J.H., Cho N.Y., Kim Y.H., Jung K.M., Yeon J.E., et al. The hepatitis B carrier rate in siblings of patients with HBV-associated chronic liver disease. Korean J Hepatol 2001, 7:387-391.
8. Giraudon I., Permalloo N., Nixon G., Charlett A., Cohuet S., Mandal S., et al. Factors associated with incomplete vaccination of babies at risk of perinatal hepatitis B transmission:a London study in 2006. Vaccine 2009, 27:2016-2022.
9. Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis 2003, 23:47-58.
10. Lazizi Y., Badur S., Perk Y., Ilter O., Pillot J. Selective unresponsiveness to HBsAg vaccine in newborns related with an in utero passage of hepatitis B virus DNA. Vaccine 1997, 15:1095-1100.
11. Theeten H., Vandermeulen C., Roelants M., Hoppenbrouwers K., Depoorter A.M., Van Damme P. Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium. Acta Paediatr 2009, 98:1307-1312.
12. Vandermeulen C., Roelants M., Theeten H., Depoorter A.M., Van Damme P., Hoppenbrouwers K. Vaccination coverage in 14-year-old adolescents: documentation, timeliness, and sociodemographic determinants. Pediatrics 2008, 121:e428-e434.
13. Macdonald V., Dore G.J., Amin J., van Beek I. Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre. Sex Health 2007, 4(1):27-30.
14. Topuridze M., Butsashvili M., Kamkamidze G., Kajaia M., Morse D., McNutt L.A. Barriers to hepatitis B vaccine coverage among healthcare workers in the Republic of Georgia: an international perspective. Infect Control Hosp Epidemiol 2010, 31:158-164.
15. Burnett R.J., Francois G., Mphahlele M.J., Mureithi J.G., Africa P.N., Satekge M.M., et al. Hepatitis B vaccination coverage in healthcare workers in Gauteng Province, South Africa. Vaccine 2011, 29:4293-4297.
16. Stuver S.O., Boschi-Pinto C., Trichopoulos D. Infection with hepatitis B and C viruses, social class and cancer. IARC Sci Publ 1997, 319-324.
17. Kim Y., Jun J.K., Choi K.S., Lee H.Y., Park E.C. Overview of the National Cancer screening programme and the cancer screening status in Korea. Asian Pac J Cancer Prev 2011, 12:725-730.
18. Khang Y.H., Lynch J.W., Yang S., Harper S., Yun S.C., Jung-Choi K., et al. The contribution of material, psychosocial, and behavioral factors in explaining educational and occupational mortality inequalities in a nationally representative sample of South Koreans: relative and absolute perspectives. Soc Sci Med 2009, 68:858-866.
19. Marshall R.J., Chisholm E.M. Hypothesis testing in the polychotomous logistic model with an application to detecting gastrointestinal cancer. Stat Med 1985, 4:337-344.
20. Khang Y.H., Lynch J.W., Kaplan G.A. Health inequalities in Korea: age- and sex-specific educational differences in the 10 leading causes of death. Int J Epidemiol 2004, 33:299-308.
21. Zuckerman A.J. More than third of world's population has been infected with hepatitis B virus. BMJ 1999, 318:1213.
22. Mansoor O.D., Wilson N. Preventing and treating hepatitis B infection: immunisation is most important strategy to control hepatitis B. BMJ 2005, 330:197-198.
23. Lee G.C., Hwang L.Y., Beasley R.P., Chen S.H., Lee T.Y. Immunogenicity of hepatitis B virus vaccine in healthy Chinese neonates. J Infect Dis 1983, 148:526-529.
24. Park N.H., Chung Y.H., Lee H.S. Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period. Intervirology 2010, 53:20-28.
25. Chan O.K., Suen S.S., Lao T.T., Leung V.K., Yeung S.W., et al. Determinants of hepatitis B vaccine uptake among pregnant Chinese women in Hong Kong. Int J Gynaecol Obstet 2009, 106:232-235.
26. Choe J.H., Taylor V.M., Yasui Y., Burke N., Nguyen T., Acorda E., et al. Health care access and sociodemographic factors associated with hepatitis B testing in Vietnamese American men. J Immigr Minor Health 2006, 8:193-201.
27. Falagas M.E., Zarkadoulia E. Factors associated with suboptimal compliance to vaccinations in children in developed countries: a systematic review. Curr Med Res Opin 2008, 24:1719-1741.
28. Shin A., Cho E.R., Kim J., Sung J., Park K.W., Lim M.K., et al. Factors associated with awareness of infection status among chronic hepatitis B and C carriers in Korea. Cancer Epidemiol Biomarkers Prev 2009, 18:1894-1898.
29. Viswanath K., Race Ackerson L.K. Race, ethnicity, language, social class, and health communication inequalities: a nationally-representative cross-sectional study. PLoS One 2011, 6:e14550.
30. Middleman A.B., Robertson L.M., Young C., Durant R.H., Emans S.J. Predictors of time to completion of the hepatitis B vaccination series among adolescents. J Adolesc Health 1999, 25:323-327.
31. Lee E.H., Han M.A., Lee H.Y., Jun J.K., Choi K.S., et al. Liver cancer screening in Korea: a report on the 2008 National Cancer Screening Programme. Asian Pac J Cancer Prev 2010, 11:1305-1310.
32. Chang E.T., Nguyen B.H., So S.K. Attitudes toward hepatitis B and liver cancer prevention among Chinese Americans in the San Francisco Bay Area, California. Asian Pac J Cancer Prev 2008, 9:1-8.
33. Pickering L.K., Baker C.J., Freed G.L., Gall S.A., Grogg S.E., Poland G.A., et al. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the infectious diseases society of America. Clin Infect Dis 2009, 49:817-840.
34. Galarce E.M., Minsky S., Viswanath K. Socioeconomic status, demographics, beliefs and A(H1N1) vaccine uptake in the United States. Vaccine 2011, 29:5284-5289.
35. Sun M., Ma R., Zeng Y., Luo F., Zhang J., Hou W. Immunization status and risk factors of migrant children in densely populated areas of Beijing, China. Vaccine 2010, 28:1264-1274.